{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:44:56Z","timestamp":1748367896581,"version":"3.40.5"},"reference-count":15,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Significant milestones have been made in the development of COVID19 diagnostics Technologies. Government of the republic of Uganda and the line Ministry of Health mandated Uganda Virus Research Institute to ensure quality of COVID19 diagnostics. Re-testing was one of the methods initiated by the UVRI to implement External Quality assessment of COVID19 molecular diagnostics.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Method<\/jats:title>\n<jats:p>participating laboratories were required by UVRI to submit their already tested and archived nasopharyngeal samples and corresponding meta data. These were then re-tested at UVRI using the WHO Berlin protocol, the UVRI results were compared to those of the primary testing laboratories in order to ascertain performance agreement for the qualitative &amp; quantitative results obtained. Ms Excel window 12 and GraphPad prism ver 15 was used in the analysis. Bar graphs, pie charts and line graphs were used to compare performance agreement between the reference Laboratory and primary testing Laboratories.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p><jats:bold>Eleven (11)<\/jats:bold> Ministry of Health\/Uganda Virus Research Institute COVID19 accredited laboratories participated in the re-testing of quality control samples. 5\/11 (45%) of the primary testing laboratories had 100% performance agreement with that of the National Reference Laboratory for the final test result. Even where there was concordance in the final test outcome (negative or positive) between UVRI and primary testing laboratories, there were still differences in CT values. The differences in the Cycle Threshold (CT) values were insignificant except for Tenna &amp; Pharma Laboratory and the UVRI(p = 0.0296). The difference in the CT values were not skewed to either the National reference Laboratory(UVRI) or the primary testing laboratory but varied from one laboratory to another. In the remaining 6\/11 (55%) laboratories where there were discrepancies in the aggregate test results, only samples initially tested and reported as positive by the primary laboratories were tested and found to be false positives by the UVRI COVID19 National Reference Laboratory.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>False positives were detected from public, private not for profit and private testing laboratories in almost equal proportion. There is need for standardization of molecular testing platforms in Uganda. There is also urgent need to improve on the Laboratory quality management systems of the molecular testing laboratories in order to minimize such discrepancies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0287272","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T18:27:46Z","timestamp":1706120866000},"page":"e0287272","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2836-7141","authenticated-orcid":true,"given":"Erick Jacob","family":"Okek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrick Joshua","family":"Masembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Kiconco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1840-1801","authenticated-orcid":true,"given":"John","family":"Kayiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Amwine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Obote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Alele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Nahabwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson","family":"Were","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bagaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Balinandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Lutwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"pone.0287272.ref001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jim.2013.09.012","article-title":"Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the external quality assurance program oversight laboratory (EQAPOL).","volume":"409","author":"CA Todd","year":"2014","journal-title":"Journal of immunological methods"},{"journal-title":"WHO manual for organizing a national external quality assessment programme for health laboratories and other testing sites","year":"2016","author":"Organization WH.","key":"pone.0287272.ref002"},{"key":"pone.0287272.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-020-00532-2","article-title":"Recent developments on therapeutic and diagnostic approaches for COVID-19","volume":"23","author":"J Majumder","year":"2021","journal-title":"The AAPS journal"},{"key":"pone.0287272.ref004","doi-asserted-by":"crossref","first-page":"615099","DOI":"10.3389\/fmed.2021.615099","article-title":"Review of current COVID-19 diagnostics and opportunities for further development","volume":"8","author":"Y Mardian","year":"2021","journal-title":"Frontiers in medicine"},{"key":"pone.0287272.ref005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijid.2021.09.020","article-title":"Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute","volume":"112","author":"T Lutalo","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"issue":"5","key":"pone.0287272.ref006","doi-asserted-by":"crossref","first-page":"e0265334","DOI":"10.1371\/journal.pone.0265334","article-title":"Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda.","volume":"17","author":"J Bwogi","year":"2022","journal-title":"Plos one"},{"issue":"7","key":"pone.0287272.ref007","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.arcmed.2020.08.007","article-title":"Biosafety concerns during the collection, transportation, and processing of COVID-19 samples for diagnosis","volume":"51","author":"K Karthik","year":"2020","journal-title":"Archives of Medical Research"},{"issue":"3","key":"pone.0287272.ref008","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00041444-200209000-00003","article-title":"Single nucleotide polymorphism detection: allelic discrimination using TaqMan","volume":"12","author":"FE McGuigan","year":"2002","journal-title":"Psychiatric genetics"},{"issue":"04","key":"pone.0287272.ref009","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bsheal.2020.07.009","article-title":"Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2.","volume":"2","author":"Y Liu","year":"2020","journal-title":"Biosafety and health."},{"issue":"2","key":"pone.0287272.ref010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpha.2020.02.010","article-title":"Recent advances and perspectives of nucleic acid detection for coronavirus","volume":"10","author":"M Shen","year":"2020","journal-title":"Journal of pharmaceutical analysis"},{"issue":"4","key":"pone.0287272.ref011","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jvh.12345","article-title":"Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review","volume":"22","author":"J Greenman","year":"2015","journal-title":"Journal of viral hepatitis"},{"key":"pone.0287272.ref012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbt.2022.04.001","article-title":"Pre-analytical sample stabilization by different sampling devices for PCR-based COVID-19 diagnostics","volume":"70","author":"M Hardt","year":"2022","journal-title":"New Biotechnology"},{"key":"pone.0287272.ref013","doi-asserted-by":"crossref","first-page":"149877","DOI":"10.1016\/j.scitotenv.2021.149877","article-title":"Minimizing errors in RT-PCR detection and quantification of SARS-CoV-2 RNA for wastewater surveillance","volume":"805","author":"W Ahmed","year":"2022","journal-title":"Science of the Total Environment"},{"key":"pone.0287272.ref014","first-page":"2020.04. 24.20078949","article-title":"Reconstructed diagnostic sensitivity and specificity of the RT-PCR test for COVID-19.","author":"NS Padhye","year":"2020","journal-title":"MedRxiv"},{"issue":"10","key":"pone.0287272.ref015","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1093\/cid\/ciaa1199","article-title":"College of American Pathologists (CAP) Microbiology Committee perspective: caution must be used in interpreting the cycle threshold (Ct) value.","volume":"72","author":"D Rhoads","year":"2021","journal-title":"Clinical Infectious Diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T18:28:04Z","timestamp":1706120884000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287272"}},"subtitle":[],"editor":[{"given":"Chika Kingsley","family":"Onwuamah","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0287272","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,1,24]]}}}